Severe skin ulcer in systemic scleroderma due to severe acute respiratory syndrome coronavirus 2 infection

Maruyama, Ayano; Ohshita, Akifumi; Katoh, Norito

doi:10.1111/1346-8138.15920

Cited by 3 publications

(4 citation statements)

References 5 publications

(9 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In Japan, 12 cases of COVID‐19‐associated viral eruptions have been reported thus far. 4 , 5 , 6 , 7 , 8 , 9 , 10 , 11 , 12 These reports are summarized in Table S2 . The total number of cases of COVID‐19‐associated viral eruption in Japan was 33, including the 21 patients we saw.…”

Section: Resultsmentioning

confidence: 99%

“…Two patients with pernio‐like lesions, known as COVID toes, have been reported in Japan, but one patient had systemic sclerosis as the primary disease. 11 Pernio‐like lesions in patients with no underlying disease are still rare, with only one case reported in Japan. There was one case each of TEN and erythema nodosum.…”

Section: Resultsmentioning

confidence: 99%

“…The types of skin manifestations and their respective rates of occurrence were as follows: erythematous papules in 27 cases (82%), urticarial in three patients (9%), pernio‐like lesions in two cases (one case combined with erythematous papules) (6%), papulovesicular type in zero patients (0%), livedo reticularis in one case (combined with erythematous papules) (3%), and others (erythema nodosum, toxic epidermal necrolysis[TEN]) in two patients (6%). Two patients with pernio‐like lesions, known as COVID toes, have been reported in Japan, but one patient had systemic sclerosis as the primary disease 11 . Pernio‐like lesions in patients with no underlying disease are still rare, with only one case reported in Japan.…”

Section: Resultsmentioning

confidence: 99%

“…In Japan, 12 cases of COVID-19-associated viral eruptions have been reported thus far. 4,5,[6][7][8][9][10][11][12] These reports are summarized in Table S2.…”

Section: Review Of Literaturementioning

confidence: 99%

See 3 more Smart Citations

Cutaneous manifestations of coronavirus disease 2019 patients in Japan

Tamai

Sakamoto

Goto

et al. 2022

The Journal of Dermatology

View full text Add to dashboard Cite

Some patients with coronavirus disease 2019 (COVID‐19) develop skin manifestations. There may be regional and racial differences in the frequency and type of COVID‐19‐associated skin manifestations. There are, however, few reports on skin manifestations in COVID‐19 patients in Asia, including Japan. We retrospectively investigated the frequency, type, and clinical course of skin manifestations in Japanese patients with COVID‐19. From 22 February 2020 to 16 August 2021, 738 Japanese patients (median age 59 years, 55% male) with laboratory‐confirmed COVID‐19 on polymerase chain reaction or antigen tests were admitted to our hospital. We mainly admitted patients with mild to moderate severity who had symptoms such as cough, fever, and oxygen demand but did not require mechanical ventilation. A total of 2.8% (21/738) of the COVID‐19 patients treated at our hospital were diagnosed with viral eruptions caused by COVID‐19. Of the 21 patients, 19 developed erythematous papules, and two developed urticaria. There were no cases of pernio‐like lesions, known as COVID toes. The median duration from the onset of other COVID‐19 symptoms to the development of skin manifestations was 9 days. This study revealed that approximately 2–3% of Japanese patients with COVID‐19 developed COVID‐19‐associated viral eruptions, most of which were erythematous papules.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

“…In Japan, 12 cases of COVID-19-associated viral eruptions have been reported thus far. 4,5,[6][7][8][9][10][11][12] These reports are summarized in Table S2.…”

Section: Review Of Literaturementioning

confidence: 99%

See 2 more Smart Citations